BioMarin Pharmaceutical (BMRN) News Today → Emergency: Biden's $20 Trillion Mistake Could Cost YOU! (From GoldenCrest Metals) (Ad) Free bmrn Stock Alerts $90.05 -0.42 (-0.46%) (As of 02:40 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLeerink Partnrs Analysts Lower Earnings Estimates for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - April 18 at 6:48 AMInternational Assets Investment Management LLC Invests $3.60 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - April 18 at 4:36 AMBioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?finance.yahoo.com - April 17 at 2:20 PMBioMarin Pharmaceutical (BMRN) Set to Announce Earnings on Wednesdayamericanbankingnews.com - April 17 at 2:50 AMBiomarin CEO sells over $3.6m in company stockinvesting.com - April 17 at 12:55 AMMirae Asset Global Investments Co. Ltd. Sells 50,979 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - April 16 at 5:04 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Director Jean Jacques Bienaime Sells 20,000 Sharesinsidertrades.com - April 16 at 4:18 AMInsider Selling: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Director Sells 20,000 Shares of Stockmarketbeat.com - April 15 at 6:47 PMErin Burkhart Sells 2,286 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stockamericanbankingnews.com - April 14 at 4:42 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Recommendation of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 14 at 2:12 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - April 14 at 2:11 AMMerck, Vertex could beat expectations despite more subdued 1Q biopharma earnings anticipated: BofAca.investing.com - April 13 at 7:43 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) CAO Erin Burkhart Sells 2,286 Sharesinsidertrades.com - April 13 at 7:09 AMInsider Sell: Biomarin Pharmaceutical Inc (BMRN) Chief Accounting Officer Erin Burkhart ...finance.yahoo.com - April 12 at 9:01 PMBioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ETprnewswire.com - April 10 at 8:00 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Assenagon Asset Management S.A.marketbeat.com - April 5 at 4:35 AMChina Universal Asset Management Co. Ltd. Has $2.14 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - April 4 at 6:54 PMInsider Selling: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) EVP Sells 24,602 Shares of Stockinsidertrades.com - April 2 at 4:10 AMInsider Sell: EVP, Chief Legal Officer George Davis Sells 24,602 Shares of Biomarin ...finance.yahoo.com - April 1 at 8:53 PMAMI Asset Management Corp Sells 86,669 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - March 30 at 11:21 PMFort Washington Investment Advisors Inc. OH Sells 142,656 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - March 25 at 2:13 PMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Average Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - March 20 at 3:40 AMVanguard Group Inc. Lowers Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - March 19 at 5:17 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Short Interest Down 6.1% in Februarymarketbeat.com - March 18 at 10:54 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Director Sells $85,510.00 in Stockinsidertrades.com - March 17 at 8:34 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Insider Henry J. Fuchs Sells 35,341 Sharesinsidertrades.com - March 17 at 6:50 AM3 B-Rated Biotech Stocks to Boost Your Bottom Linestocknews.com - March 15 at 10:12 AMBMRN May 2024 90.000 callfinance.yahoo.com - March 15 at 5:30 AMDNB Asset Management AS Sells 111,156 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - March 14 at 10:49 AMBraun Stacey Associates Inc. Sells 177,727 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - March 12 at 9:33 AMNew Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meetingprnewswire.com - March 12 at 8:30 AMBioMarin Pharmaceutical: Pioneering Innovations Are Driving Future Growthfinance.yahoo.com - March 11 at 1:46 PMSeven Eight Capital LP Has $235,000 Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - March 11 at 7:11 AMAQR Capital Management LLC Decreases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - March 10 at 5:55 AMInsider Sell: President, Worldwide R&D Henry Fuchs Sells 35,341 Shares of Biomarin ...finance.yahoo.com - March 8 at 3:06 AMAnalysts Have Conflicting Sentiments on These Healthcare Companies: BioMarin Pharmaceutical (BMRN) and Andlauer Healthcare Group (OtherANDHF)markets.businessinsider.com - March 7 at 12:04 PMBioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officerprnewswire.com - March 7 at 8:30 AMBioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officerprnewswire.com - March 7 at 8:30 AMQube Research & Technologies Ltd Sells 407,530 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - March 5 at 8:24 AMEULAV Asset Management Has $11.68 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - March 4 at 11:17 AMCalifornia State Teachers Retirement System Sells 13,173 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - March 3 at 7:32 AMEnvestnet Asset Management Inc. Has $11.13 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - March 2 at 5:11 AMBuy Rating Justified by BioMarin’s Strategic R&D and Voxzogo’s Market Potentialmarkets.businessinsider.com - March 1 at 5:50 PMBioMarin Scheduled to Participate in March Investor Conferencesprnewswire.com - March 1 at 9:00 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Fmr LLCmarketbeat.com - March 1 at 5:00 AMSherbrooke Park Advisers LLC Invests $1.11 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - February 29 at 10:01 AMFY2024 Earnings Estimate for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Issued By Cantor Fitzgeraldmarketbeat.com - February 29 at 8:53 AMBioMarin Pharmaceutical: Still Has A Lot Of Room For Growthseekingalpha.com - February 29 at 12:39 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by DSC Advisors L.P.marketbeat.com - February 28 at 4:20 PMJustice Department targets another Bay Area drug maker's sponsored testing programbizjournals.com - February 27 at 2:32 PM Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars (Ad)Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver. Learn More Now BMRN Media Mentions By Week BMRN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼0.500.49▲Average Medical News Sentiment BMRN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼176▲BMRN Articles Average Week Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALNY News Today IONS News Today MDGL News Today ALKS News Today TEVA News Today BGNE News Today VTRS News Today GMAB News Today KRTX News Today RDY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold[Urgent!] Generational Wealth GameplanCrypto 101 MediaEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsNext President (Not Trump. Not Biden.)The Freeport SocietyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.